鍋倉 宰
Nabekura, Tsukasa
愛知県がんセンター 研究所 , 腫瘍免疫応答研究分野 , 分野長 Aichi Cancer Center, Research Institute , Division of Immune Response , Chief
-
1.
Dual Knockout of Fas and TCRα in Jurkat Reporter Cells Enables Highly Sensitive Identification of Antigen-Specific TCRs
Yujia Sun; Ayako Demachi-Okamura; Shuichi Shinohara; Wang Yizheng (+4 著者) Daisuke Muraoka
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 805: 153400 (2026) Semantic Scholar
-
2.
CAR-NK細胞開発に資するNK細胞の知見
鍋倉宰
実験医学 44: 355 (2026)
-
3.
Functional and structural analysis of KK-LC-1-specific T cell receptors from patients with lung Cancer for immunotherapy
Yasunori Fukushima; Yizheng Wang; Yuki Yada-Makino; Hiroyasu Komuro (+19 著者) Daisuke Muraoka
CELLULAR IMMUNOLOGY 419: 105059 (2025) Semantic Scholar
-
4.
Quiescent ILC1 cells confer protection against MCMV infection during undernutrition
Megumi Tatematsu; Shunsuke Takasuga; Akane Fuchimukai; Shinsuke Seki (+7 著者) Takashi Ebihara
CELL REPORTS 44: 116644 (2025) Semantic Scholar
-
5.
NK細胞の免疫記憶分化機構
鍋倉 宰
臨床免疫・アレルギー科 84: 490 (2025)
-
6.
The difference in tumor immune microenvironment and IFN-γ response between solid and non-solid adenocarcinoma
Shuichi Shinohara; Daisuke Muraoka; Ayako Demachi-Okamura; Katsuhiro Masago (+14 著者) Hirokazu Matsushita
TRANSLATIONAL LUNG CANCER RESEARCH 14: 3753 (2025) Semantic Scholar
-
7.
Immunological memory in natural killer cells
Nabekura,Tsukasa
INTERNATIONAL IMMUNOLOGY 37: 435 (2025)
-
8.
Tn antigen suppresses lipopolysaccharide-induced dermatitis via Clec10a
Katsunobu Shigematsu; Kenshiro Matsuda; Tsukasa Nabekura; Kazumasa Kanemaru (+2 著者) Akira Shibuya
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 772: 152024 (2025)
-
9.
1. CD96 enhances the anti-viral activity of natural killer cells by promoting Ly49H-mediated activation during mouse cytomegalovirus infection
Nabekura,Tsukasa; Matsuo,Soichi; Shibuya,Kazuko; Shibuya,Akira
MOLECULAR IMMUNOLOGY 179: 65 (2025)
-
10.
NK細胞の免疫記憶
鍋倉 宰
臨床免疫・アレルギー科 82: 461 (2024)
-
11.
Concanavalin A-induced acute liver injury in mice
Nabekura,Tsukasa; Matsuo,Soichi; Shibuya,Akira
CURRENT PROTOCOLS 4: e1117 (2024)
-
12.
THEMIS2 Impairs Antitumor Activity of NK Cells by Suppressing Activating NK Receptor Signaling
Deborah, Elfira Amalia; Nabekura, Tsukasa; Shibuya, Kazuko; Shibuya, Akira
JOURNAL OF IMMUNOLOGY 212: 1819 (2024)
-
13.
Themis2 regulates natural killer cell memory function and formation
Nabekura, Tsukasa; Deborah; Elfira Amalia; Tahara, Saeko (+5 著者) Shibuya, Akira
NATURE COMMUNICATIONS 14: 7200 (2023) Semantic Scholar
-
14.
DNAM-1 immunoreceptor protects mice from concanavalin A-induced acute liver injury by reducing neutrophil infiltration.
Matsuo, Soichi; Nabekura, Tsukasa; Matsuda, Kenshiro; Shibuya, KazukoShibuya, Akira
JOURNAL OF IMMUNOLOGY 211: 954 (2023)
-
15.
Liver type 1 innate lymphoid cells lacking IL-7 receptor are a native killer cell subset fostered by parenchymal niches
Asahi, Takuma; Abe, Shinya; Cui, Guangwei; Shimba, Akihiro (+8 著者) Ikuta, Koichi
ELIFE 12: e84209 (2023) Semantic Scholar
-
16.
The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells
Aguilar, Oscar A.; Gonzalez-Hinojosa; Maria D R.; Arakawa-Hoy (+4 著者) Lanier, Lewis L.
JOURNAL OF LEUKOCYTE BIOLOGY 113: 27 (2023) Semantic Scholar
-
17.
Early reactivation of clustered genes on the inactive X chromosome during somatic cell reprogramming
Aizawa, Shiho; Nishimura, Ken; Mondejar; Gonzalo Seminario (+12 著者) Hisatake, Koji
STEM CELL REPORTS 17: 53 (2022) Semantic Scholar
-
18.
Selective expression of a C-type lectin receptor, Clec12b, on skin mast cells
Iijima, Ayana; Kanemaru, Kazumasa; Wang, Yaqiu; Nabekura, Tsukasa (+6 著者) Shibuya, Akira
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 561: 101 (2021) Semantic Scholar
-
19.
Type 1 innate lymphoid cells: Soldiers at the front line of immunity
Tsukasa Nabekura; Akira Shibuya
BIOMEDICAL JOURNAL 44: 115 (2021) Semantic Scholar
-
20.
ILC1: guardians of the oral mucosa against enemy viruses
Nabekura, Tsukasa; Shibuya, Akira
IMMUNITY 54: 196 (2021) Semantic Scholar
-
1.
An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
鍋倉, 宰
2008年3月
-
41.
Identification and characterization of the poliovirus receptor(CD155)as a novel co-stimulatory molecule in CD4+ T cells.
Yamashita, Y; Wang, Y; Yoshioka, A; Nabekura, T; Tahara-Hanaoka, S; Honda, S; Shibuya, K; Shibuya, A
The 14th International Congress of Immunology 2010年8月
-
42.
DNAM-1は移植片対宿主病の発症において重要な役割を果たす
鍋倉, 宰; 渋谷, 和子; 竹中, 江里; 渋谷, 彰
第20回Kyoto T Cell Conference 2010年6月
-
43.
A critical role of DNAM-1 in the development of acute graft-versus-host disease
Nabekura,Tsukasa
The Keystone Symposia on Molecular and Cellular Biology (Lymphocyte Activation) 2010年2月
-
44.
Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
Nabekura,Tsukasa
第39回日本免疫学会学術集会 2009年12月
-
45.
Novel prophylactic and therapeutic approaches to GVHD with a monoclonal antibody against DNAM-1
Nabekura,Tsukasa
第71回日本血液学会総会 2009年10月
-
46.
遺伝子導入樹状細胞ワクチンによる腫瘍特異的T細胞の誘導
鍋倉 宰; 長澤俊郎; 中内啓光; 小野寺雅史
第18回Kyoto T Cell Conference 2008年6月
-
47.
An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
Nabekura,Tsukasa
第37回日本免疫学会学術集会 2007年11月
-
48.
Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura,Tsukasa
第13回日本遺伝子治療学会学術集会 2007年6月
-
49.
Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura,Tsukasa
第36回日本免疫学会学術集会 2006年12月
-
50.
Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura,Tsukasa
第12回日本遺伝子治療学会学術集会 2006年8月
-
51.
Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura,Tsukasa
第35回日本免疫学会学術集会 2005年12月
-
52.
Feasibility of vaccine therapy with dendritic cells genetically modified to express the tumor-associated antigen HER2
Nabekura,Tsukasa
第11回日本遺伝子治療学会学術集会 2005年7月
-
53.
Potent cancer immunotherapy with dendritic cells generated from genetically modified hematopoietic stem cells
Nabekura,Tsukasa
The 7th Annual Meeting of the American Society of Gene Therapy 2004年6月
-
54.
Establishment of a novel cancer immunotherapy with genetically modified dendritic cells.
Nabekura,Tsukasa
第33回日本免疫学会学術集会 2003年12月
-
55.
The scaffold protein Themis2 limits natural killer memory formation during mouse cytomegalovirus infection
Nabekura, Tsukasa
International Symposium on Immune Regulation 招待有り
-
1. UC Case No: 2017-134, Research Tool Disclosure (invention): NKp46-CreERT2 transgenic mice
Nabekura, Tsukasa; Lanier, L Lewis -
2. UC Case No: 2017-134, Research Tool Disclosure (invention): NKp46-CreERT2 transgenic mice
Nabekura, Tsukasa; Lanier, L Lewis -
3. : ACTIVITY MODULATOR, MEDICINAL AGENT COMPRISING SAME, USE OF CD300A GENE-DEFICIENT MOUSE, AND ANTI-CD300A ANTIBODY
渋谷 彰; 小田 ちぐさ; 田原 聡子; Nabekura, Tsukasa; カンカーナム ガマゲ; サナトゥ ウダヤンガ; 三木 春香; 飯野 秀一 -
4. UC Case No: 2017-134, Research Tool Disclosure (invention): NKp46-CreERT2 transgenic mice
Nabekura, Tsukasa; Lanier, L Lewis -
5. : ベクターによる遺伝子改変型樹状細胞を用いた抗体作製方法
小野寺, 雅史; 大津, 真; 鍋倉, 宰 -
6. : レトロウイルスを用いて改変された細胞を用いた養子免疫遺伝子細胞治療
小野寺, 雅史; 濱仲, 早苗; 鍋倉, 宰; 中内, 啓光 -
7. : ACTIVITY MODULATOR, MEDICINAL AGENT COMPRISING SAME, USE OF CD300A GENE-DEFICIENT MOUSE, AND ANTI-CD300A ANTIBODY
渋谷 彰; 小田 ちぐさ; 田原 聡子; 鍋倉 宰; カンカーナム ガマゲ; サナトゥ ウダヤンガ; 三木 春香; 飯野 秀一 -
8. UC Case No: 2017-134, Research Tool Disclosure (invention): NKp46-CreERT2 transgenic mice
Nabekura, Tsukasa; Lanier, L Lewis -
9. 特願2013-545868: 活性調節剤、これを含有する医薬品、および抗CD300a抗体
渋谷, 彰; 小田 ちぐさ; 田原 聡子; 鍋倉 宰; カンカーナム ガマゲ; サナトゥ ウダヤンガ; 三木 春香; 飯野 秀一 -
10. 特開2014-095570: セリアック病に関連する、CD300a遺伝子欠損マウスおよびCD300a発現細胞の活性調節剤の使用、ならびにCD300a発現細胞の活性調節剤を含有する医薬品
渋谷,彰; 小田 ちぐさ; 鍋倉 宰 -
11. WO/2013/077186: Activity modulator, medical agent comprising same, use of CD300a gene-deficient mouse, and anti-CD330a antibody
鍋倉,宰
533 total views



ORCID